The reporting rate of euthanasia and physician-assisted suicide a study of the trends

Medical Care

Volumn 46, Issue 12, 2008, Pages 1198-1202

  Rurup, Mette L ^a   Buiting, Hilde M ^b   Pasman, H Roeline W ^a   Van Der Maas, Paul J ^b   Van Heide, Agnes Der ^b   Onwuteaka Philipsen, Bregje D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

End of life care (231.000); Euthanasia (239.000); Health policy (294.000); International health (355.000); Medical decision making (390.000)

Indexed keywords

EID: 57649108588     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31817d69e8     Document Type: Article

References (16)

1. Royal Dutch Society for the Advancement of Pharmacy (KNMP). Utilization and Preparation of Euthanasia Drugs. The Hague, The Netherlands: KNMP; 1998 [In Dutch].
2. van der Heide A, Onwuteaka-Philipsen BD, Rurup ML, et al. End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med. 2007;356:1957-1965.
3. Rurup ML, Onwuteaka-Philipsen BD, van der Heide A, et al. Trends in the agents used for euthanasia and the relationship with the number of notifications. Ned Tijdschr Geneeskd. 2006;150:618-624 [In Dutch].
4. Van Der Maas PJ, Van Delden JJ, Pijnenborg L, et al. Euthanasia and other medical decisions concerning the end of life. Lancet. 1991;338:669-674.
5. van der Maas PJ, van der Wal G, Haverkate I, et al. Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990-1995. N Engl J Med. 1996;335:1699-1705.
6. Onwuteaka-Philipsen BD, van der Heide A, Koper D, et al. Euthanasia and other end-of-life decisions in the Netherlands in 1990. 1995. and 2001. Lancet. 2003;362:395-399.
7. Onwuteaka-Philipsen BD, Gevers JKM, van der Heide A, et al. Evaluation of the Euthanasia Act. Den Haag: ZonMw; 2006 [In Dutch].
8. Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet. 2000;356:398-399.
9. Morita T, Tsunoda J, Inoue S, et al. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage. 2001;21:282-289.
10. Sykes N, Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol. 2003;4:312-318.
11. Bercovitch M, Adunsky A. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it? Cancer. 2004; 101:1473-1477.
12. Vitetta L, Kenner D, Sali A. Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life. Am J Hosp Palliai Care. 2005;22:465-473.
13. Good PD, Ravenscroft PJ, Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J. 2005;35:512-517.
14. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage. 2006;32:532-540.
15. Neil DA, Coady CA, Thompson J, et al. End-of-life decisions in medical practice: a survey of doctors in Victoria (Australia). J Med Ethics. 2007;33:721-725.
16. Peretti-Watel P, Bendiane MK, Galinier A, et al. French physicians' attitudes toward legalisation of euthanasia and the ambiguous relationship between euthanasia and palliative care. J Palliat Care. 2003;19: 271-277.